| Challenge in treating COVID‐19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels PB Ekinci, E Kara, AG Er, AC Inkaya, K Demirkan, O Uzun British Journal of Clinical Pharmacology 88 (3), 1387, 2022 | 4 | 2022 |
| Battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistin FN Ballı, PB Ekinci, M Kurtaran, E Kara, GT Dizman, MÇ Sönmezer, ... International journal of antimicrobial agents 63 (2), 107035, 2024 | 2 | 2024 |
| Colistin Induced Nephrotoxicity: Experience from a University Hospital P Bakır Ekinci, M Kurtaran, E Kara, H Avcı, S Demirkan, G Metan Mediterranean Journal of Infection Microbes and Antimicrobials 10, 2021 | 2 | 2021 |
| Voriconazole therapeutic drug level monitoring: A university hospital experience E KARA, P BAKIR EKİNCİ, G METAN, A EKİNCİOĞLU, A PINAR, ... FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI 27 (1), 2022 | 1 | 2022 |
| OBEZ HASTALARDA ANTİMİKROBİYAL İLAÇ DOZLARI M Bahap, PB Ekinci, AB Ekincioğlu, K Demirkan Sürekli Tıp Eğitimi Dergisi 29 (2), 381-442, 2020 | 1 | 2020 |
| Evaluation of empirical antibacterial treatments of coronavirus disease 2019 patients diagnosed with community-acquired pneumonia PB Ekinci, E Kara, GT Dizman, MC Sonmezer, AC Inkaya, K Demirkan, ... Journal of Critical Care 81, 154626, 2024 | | 2024 |
| Compliance with guideline recommendations in the management of patients with hospitalized community-acquired pneumonia PB Ekinci, E Kara, GT Dizman, S Metin, AC Inkaya, K Demirkan, L Coplu, ... Journal of investigative medicine: the official publication of the American …, 2024 | | 2024 |
| Compliance with guideline recommendations in the management of patients with hospitalized community-acquired pneumonia P Bakir Ekinci, E Kara, G Telli Dizman, S Metin, AC Inkaya, K Demirkan, ... Journal of Investigative Medicine, 10815589241232366, 2024 | | 2024 |
| Compliance with guideline recommendations in the management of patients with hospitalized community-acquired pneumonia P Bakir Ekinci, E Kara, G TELLİ DİZMAN, S Metin, A İNKAYA, S Demirkan, ... Journal of Investigative Medicine 72 (4), 2024 | | 2024 |
| Initial Empirical Antibiotic Treatment in Covid-19 Patients is Related with Excess Adverse Drug Reactions Without Clinical Benefit PB EKİNCİ, E KARA, GT DİZMAN, MÇ SÖNMEZER, AÇ İNKAYA, ... | | 2023 |
| Drug-related problems in internal medicine wards M Bahap, M Kurtaran, P Bakir-Ekinci, E Kara, G Sain-Guven, SG Oz, ... INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 44 (6), 1527-1527, 2022 | | 2022 |
| Vorikonazol Terapötik İlaç Düzeyi İzlemi: Bir Üniversite Hastanesi Deneyimi E Kara, PB Ekinci, G Metan, AB Ekincioğlu, A Pınar, M Akova, Ö Uzun Flora the Journal of Infectious Diseases and Clinical Microbiology 27 (1 …, 2022 | | 2022 |
| Liposomal Amphotericin B Induced Acute Reactions M Bahap, PB Ekinci, S Alp, SG Oz, K Demirkan Acta Medica 52 (4), 361-364, 2021 | | 2021 |
| Cross-Reactivity to Meropenem and Ertapenem Without Imipenem. PB Ekinci, E Kara, A Yalcin, K Demirkan, O Uzun Journal of Critical and Intensive Care 11 (1), 28-31, 2020 | | 2020 |
| Cross-Reactivity to Meropenem and Ertapenem Without Imipenem. P BAKIR EKINCI, E KARA, A YALCIN, K DEMIRKAN, O UZUN Turkish Journal of Medical & Surgical Intensive Care Medicine/Dahili ve …, 2020 | | 2020 |
